Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 12:22 pm Purchase | 2024-12-31 | 13G | Structure Therapeutics Inc. GPCR | JANUS HENDERSON GROUP PLC JHG | 4,159,888 7.300% | 203,010 (+5.13%) | Filing History |
| 2025-01-13 4:08 pm Purchase | 2025-01-06 | 13G | Structure Therapeutics Inc. GPCR | Deep Track Capital LP | 9,000,000 5.240% | 8,100,000 (+900.00%) | Filing History |
| 2024-11-14 5:46 pm Sale | 2024-09-30 | 13G | Structure Therapeutics Inc. GPCR | RA CAPITAL MANAGEMENT LLC | 5,690,316 3.300% | -1,534,995 (-21.24%) | Filing History |
| 2024-11-14 10:26 am Purchase | 2024-09-30 | 13G | Structure Therapeutics Inc. GPCR | JANUS HENDERSON GROUP PLC JHG | 3,956,878 6.900% | 3,956,878 (New Position) | Filing History |
| 2024-11-14 09:33 am Sale | 2024-09-30 | 13G | Structure Therapeutics Inc. GPCR | AVORO CAPITAL ADVISORS LLC | 0 0.000% | -6,999,999 (Position Closed) | Filing History |
| 2024-11-12 12:52 pm Purchase | 2024-11-07 | 13G | Structure Therapeutics Inc. GPCR | Capital Research Global Investors | 10,591,350 6.200% | 10,591,350 (New Position) | Filing History |
| 2024-11-12 10:34 am Purchase | 2024-11-08 | 13G | Structure Therapeutics Inc. GPCR | FMR LLC | 23,586,870 14.999% | 23,586,870 (New Position) | Filing History |
| 2024-11-08 10:52 am Purchase | 2024-09-30 | 13G | Structure Therapeutics Inc. GPCR | WELLINGTON MANAGEMENT CO LLP | 23,309,313 13.950% | 10,192,335 (+77.70%) | Filing History |
| 2024-05-30 6:57 pm Purchase | 2024-05-20 | 13G | Structure Therapeutics Inc. GPCR | RA CAPITAL MANAGEMENT LLC | 7,225,311 5.200% | 7,225,311 (New Position) | Filing History |
| 2024-02-14 09:07 am Purchase | 2023-12-31 | 13G | Structure Therapeutics Inc. GPCR | AVORO CAPITAL ADVISORS LLC | 6,999,999 5.000% | 6,999,999 (New Position) | Filing History |
| 2024-02-14 08:45 am Sale | 2023-12-31 | 13G | Structure Therapeutics Inc. GPCR | Deep Track Capital LP | 900,000 0.660% | -7,040,346 (-88.67%) | Filing History |
| 2024-02-09 09:49 am Purchase | 2024-02-08 | 13G | Structure Therapeutics Inc. GPCR | FMR LLC | 17,372,856 12.703% | 3,884,664 (+28.80%) | Filing |
| 2024-02-09 07:59 am Purchase | 2024-02-08 | 13G | Structure Therapeutics Inc. GPCR | FIL Ltd | 27,912 0.020% | 27,912 (New Position) | Filing History |
| 2024-02-08 10:03 am Sale | 2023-12-29 | 13G | Structure Therapeutics Inc. GPCR | WELLINGTON MANAGEMENT CO LLP | 13,116,978 9.430% | -2,763,258 (-17.40%) | Filing History |
| 2024-02-06 11:01 am Purchase | 2024-01-31 | 13G | Structure Therapeutics Inc. GPCR | WELLINGTON MANAGEMENT CO LLP | 15,880,236 11.410% | 15,880,236 (New Position) | Filing History |
| 2023-12-20 4:36 pm Sale | 2023-12-18 | 13G | Structure Therapeutics Inc. GPCR | BIOTECHNOLOGY VALUE FUND L P | 2,438,964 1.800% | -10,221,554 (-80.74%) | Filing History |
| 2023-10-13 4:00 pm Purchase | 2023-10-04 | 13G | Structure Therapeutics Inc. GPCR | FMR LLC | 13,488,192 10.756% | 4,073,636 (+43.27%) | Filing |
| 2023-10-04 12:01 pm Purchase | 2023-10-04 | 13G | Structure Therapeutics Inc. GPCR | FIL Ltd | 13,488,192 10.756% | 7,014,431 (+108.35%) | Filing |
| 2023-02-13 5:28 pm Purchase | 2023-02-03 | 13G | Structure Therapeutics Inc. GPCR | BIOTECHNOLOGY VALUE FUND L P | 12,660,518 11.100% | 12,660,518 (New Position) | Filing History |
| 2023-02-10 09:13 am Purchase | 2023-02-09 | 13G | Structure Therapeutics Inc. GPCR | FIL Ltd | 6,473,761 5.897% | 6,473,761 (New Position) | Filing |